Rapid Therapeutic Science Laboratories, Inc. financial data

Symbol
RTSL on OTC
Industry
Pharmaceutical Preparations
Location
558 County Road 472, De Leon, TX
State of incorporation
NV
Fiscal year end
December 31
Former names
Holly Brothers Pictures, Inc. (to 1/21/2020), PowerMedChairs (to 5/9/2017)
Latest financial report
10-Q - Q2 2023 - Aug 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 5.54 % -62.2%
Quick Ratio 3.73 % -21%
Debt-to-equity -173 % +23.4%
Return On Equity 118 %
Return On Assets -127 % +16.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.83M shares +14%
Common Stock, Shares, Outstanding 8.83M shares +14%
Entity Public Float 5.47M USD -89.1%
Common Stock, Value, Issued 8.83K USD +14%
Weighted Average Number of Shares Outstanding, Basic 8.32M shares +7.38%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
General and Administrative Expense 524K USD -74.1%
Nonoperating Income (Expense) 607K USD +64%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 59.6K USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -3.06M USD -39.8%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.16K USD -98.1%
Inventory, Net 175K USD 0%
Assets, Current 318K USD -10.2%
Property, Plant and Equipment, Net 1.29M USD -15.4%
Operating Lease, Right-of-Use Asset 298K USD -22.2%
Intangible Assets, Net (Excluding Goodwill) 170K USD 0%
Assets 2.07M USD -14.6%
Liabilities, Current 4.43M USD -8.95%
Operating Lease, Liability, Noncurrent 238K USD -29.7%
Liabilities 4.81M USD -10%
Retained Earnings (Accumulated Deficit) -10.1M USD +0.59%
Stockholders' Equity Attributable to Parent -2.74M USD +6.17%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -2.74M USD +6.17%
Liabilities and Equity 2.07M USD -14.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -41.8K USD +94%
Net Cash Provided by (Used in) Financing Activities 59.4K USD -89.7%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 800M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 17.6K USD
Deferred Tax Assets, Valuation Allowance 1.15M USD -1.97%
Deferred Tax Assets, Gross 1.15M USD -1.97%
Operating Lease, Liability 339K USD -18.6%
Depreciation 24K USD +4.06%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Property, Plant and Equipment, Gross 1.35M USD -13.5%
Operating Lease, Liability, Current 101K USD +30.2%
Additional Paid in Capital 7.67M USD +1.58%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 103K USD +4.35%
Amortization of Intangible Assets 0 USD -100%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 45K USD -4.54%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Operating Leases, Future Minimum Payments, Due in Three Years 107K USD +4.17%
Interest Expense 589K USD -78.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares